Dismissive Providers, Limited AI Regs, Fake Drugs On ECRI List Of Top Safety Threats

Dismissal of patient concerns by providers, insufficient artificial intelligence governance and increased market penetration of substandard and falsified drugs are on ECRI and the Institute for Safe Medication Practices' (ISMP) list of the top 10 patient safety concerns for this year. ECRI and ISMP curated the list through input from both staff and members of the public. Providers’ inadequate response to patient concerns is ranked the highest threat to patient safety on ECRI’s list for 2025. Citing a study...